Centrus Energy (LEU) Q4 2025 earnings review

War Chest Explodes to $2B, But Earnings Quality Deteriorates

Centrus Energy delivered a mixed Q4. While the headline story is the massive balance sheet expansion—cash reached nearly $2 billion via debt and equity raises—the operational reality was harsh. Q4 Net Income collapsed 67% YoY to $17.8M, and gross margins compressed significantly. However, the long-term thesis solidified with a $900M DOE HALEU award and NNSA sole-source notification. Investors are now betting on the $3.8B backlog and government awards, ignoring the current earnings volatility.

🐂 Bull Case

Government Funding Secured

The long-awaited DOE validation arrived: Centrus was selected for a $900M HALEU production award and notified of NNSA's intent to sole-source uranium enrichment. This validates the 'US-only technology' moat.

Capitalized for Growth

With nearly $2B in unrestricted cash, Centrus has removed financing risk for its Piketon facility expansion. The company can now self-fund the industrial build-out while negotiating government task orders.

🐻 Bear Case

Operational Profitability Collapse

Q4 Net Income fell 67% YoY, and Technical Solutions FY25 gross profit plummeted 66% (from $17.6M to $6.0M). The company is currently struggling to monetize its contracts efficiently due to delays in fee definitization.

Stagnant Revenue Growth

Despite the nuclear renaissance narrative, FY25 revenue grew only 1.5% ($448.7M vs $442.0M), and 2026 guidance ($425-475M) implies flat growth at the midpoint. The valuation reflects growth that hasn't materialized in the P&L yet.

⚖️ Verdict: ⚪

Neutral. The strategic positioning is perfect (DOE awards, cash pile), but the financials are messy. Paying a premium for flat revenue growth and collapsing margins requires total faith in the 2027+ execution story.

Key Themes

CONCERNNEW🔴🔴

Technical Solutions Margin Collapse

A severe deterioration in the Technical Solutions segment went largely unnoticed in the headline noise. While segment revenue grew 11% in FY25, Cost of Sales jumped 30%. The result: FY Gross Profit collapsed 66% to just $6.0M. Management blames 'undefinitized' fees due to contract extensions, but this reveals how dependent profitability is on government paperwork timing.

DRIVERNEW🟢🟢

The $900 Million DOE Award

On Jan 5, 2026, DOE selected Centrus for a $900M task order to expand HALEU production. This is the 'holy grail' catalyst investors waited for throughout 2025. While subject to negotiation, it provides the revenue visibility needed to justify the massive CapEx ramp.

DRIVERNEW🟢

NNSA Sole Source Intent

The National Nuclear Security Administration (NNSA) notified Centrus of its intent to sole-source certain enrichment activities. This confirms Centrus as the *only* viable option for US national security needs, effectively creating a monopoly for classified/defense-related enrichment.

CONCERN🔴

Extreme Quarterly Volatility

The LEU segment remains lumpy and unpredictable. Q4 Revenue dropped 3.5% YoY, and Gross Margin in the quarter compressed significantly (24% vs 40% a year ago). The company cites 'contract mix,' but the inability to deliver consistent quarterly margins makes modeling difficult.

DRIVERNEW🟢

Domestic Centrifuge Manufacturing Launch

In December 2025, Centrus initiated domestic centrifuge manufacturing to support its $2.3B LEU backlog. This moves the company from 'planning' to 'building,' supported by the new $1.96B cash position.

Other KPIs

LEU Segment Revenue (FY25)$346.2 million

Stable/Stagnant. Revenue decreased slightly (1%) from $349.9M in FY24. Higher SWU volume (+23%) was offset by lower Uranium revenue (-54%). The core business is treading water while waiting for the expansion.

Backlog (FY25)$3.8 billion

Up slightly from $3.7B at year-end 2024. Crucially, $2.3B of the LEU backlog is contingent on financing/construction. The new $900M HALEU award is *not* fully reflected here yet as it is subject to negotiation.

Cost of Sales - Technical Solutions (FY25)$96.5 million

Accelerating. Costs jumped 30% YoY ($22M increase) while revenue only grew 11%. This negative operating leverage crushed segment margins.

Guidance

2026 Total Revenue$425 - $475 million

Stable. The midpoint ($450M) implies virtually zero growth vs FY25 ($448.7M). Investors pricing in a growth story will have to wait until 2027 for the top line to move materially.

2026 Capital Deployment$350 - $500 million

Accelerating massively. Up from ~$20M in FY25. This confirms the 'industrial build-out' is starting immediately, funded by the recent capital raises.

Key Questions

Technical Solutions Margin Recovery

With FY25 gross profit in Technical Solutions down 66% due to undefinitized contracts, when exactly in 2026 will these fees be finalized, and will they be retroactive?

Cash Burn vs Deployment

You have ~$2B in cash and guide for up to $500M in deployment in 2026. Is the remaining $1.5B earmarked for specific unannounced phases, or is the war chest simply over-funded right now?

NNSA Contract Sizing

Regarding the NNSA sole-source notification—does this fall under the Technical Solutions segment or LEU, and what is the magnitude of revenue opportunity relative to the commercial LEU backlog?